Setting 
My Cart
Toggle Nav
Close
  • Menu
  • Setting

PHA-767491 HCl

Catalog No.
C9057
An ATP-competitive dual-target DDK/CDK9 inhibitor for cell cycle and transcription research.
Grouped product items
Size Price Stock Qty
5mg
$51.00
Ship with 5-10 days
10mg
$74.00
Ship with 5-10 days
25mg
$119.00
Ship with 5-10 days
50mg
$168.00
Ship with 5-10 days
100mg
$272.00
Ship with 5-10 days
200mg
Please inquire
Ship with 5-10 days
500mg
Please inquire
Ship with 5-10 days
For scientific research use only and should not be used for diagnostic or medical purposes.

Tel: +1-832-696-8203

Email: [email protected]

Worldwide Distributors

Background

PHA-767491 HCl (CAS No.: 942425-68-5) is a synthetic small-molecule, ATP-competitive dual-target kinase inhibitor that specifically acts on the Cdc7–Dbf4 complex (DDK) and cyclin-dependent kinase 9 (CDK9). It serves as a laboratory research tool for dissecting DNA replication control and transcriptional regulation, belongs to the category of cell cycle and kinase pathway probes, and is mainly applied in studies of DNA replication initiation, MCM helicase activation, and RNA polymerase II-dependent transcription elongation. Mechanistically, by inhibiting DDK, it blocks phosphorylation-dependent activation of the MCM complex and replication origin firing, induces replication stress, and leads to S-phase arrest; meanwhile, inhibition of CDK9 can reduce phosphorylation of the Ser2 site in the C-terminal domain of RNA polymerase II, thereby modulating transcription elongation and related gene expression programs. Biochemical assays show that it has nanomolar potency against DDK and CDK9, with IC50 values of approximately 10 nM and 34 nM, respectively, and exhibits about 20-fold selectivity over GSK3-β and CDK1/2, about 50-fold selectivity over CDK5 and MK2, and about 100-fold selectivity over CHK2 and PLK1, supporting mechanistic studies that require a certain degree of target discrimination. In cellular experiments, its activity is typically in the nanomolar to low micromolar range, can inhibit DNA synthesis markers, and can trigger readout signals related to programmed cell death in some tumor-derived cell lines, consistent with on-target intervention in the replication and transcription axis. Typical applications include target validation, signaling pathway dissection, and dependency screening. It can be used as a single-agent treatment or combined with other perturbing factors to map synthetic vulnerability profiles, and may be used in ethically approved animal models for pharmacodynamic or biomarker dynamic observations. The concentration or dose used in experiments usually depends on the specific experimental design and research objectives. This material is for laboratory research use only and is strictly prohibited for human or veterinary-related applications.

Chemical Properties

StorageStore at -20°C
M.Wt249.7
Cas No.942425-68-5
FormulaC12H12ClN3O
SynonymsPHA-767491 hydrochloride; CAY10572 hydrochloride; NMS 1116354 hydrochloride
Canonical SMILESO=C1C2=C(NC(C3=CC=NC=C3)=C2)CCN1.[H]Cl
Shipping ConditionSmall Molecules with Blue Ice, Modified Nucleotides with Dry Ice.
General tips We do not recommend long-term storage for the solution, please use it up soon.

User Guide